60. L. Wang, Y.F. Li, L. Zhou, Y. Liu, L. Meng, K. Zhang et al., Characterization of gold
nanorods in vivo by integrated analytical techniques: their uptake, retention, and chemical
forms. Anal. Bioanal. Chem. 396(3), 1105–1114 (2010)
61. J. Xiao, X.M. Tian, C. Yang, P. Liu, N.Q. Luo, Y. Liang et al., Ultrahigh relaxivity and safe
probes of manganese oxide nanoparticles for in vivo imaging. Sci. Rep. 3, 3424 (2013)
62. P. Bourrinet, H.H. Bengele, B. Bonnemain, A. Dencausse, J.-M. Idee, P.M. Jacobs et al.,
Preclinical safety and pharmacokinetic profile of ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent. Invest. Radiol. 41(3), 313–324 (2006)
63. C. Liu, Z. Gao, J. Zeng, Y. Hou, F. Fang, Y. Li et al., Magnetic/upconversion fluorescent
NaGdF4:Yb, Er nanoparticle-based dual-modal molecular probes for imaging tiny tumors
in vivo. ACS Nano 7(8), 7227–7240 (2013)
64. Y.N. Zhang, W. Poon, A.J. Tavares, I.D. McGilvray, W.C. Chan, Nanoparticle-liver
interactions: Cellular uptake and hepatobiliary elimination. J. Control Release 240, 332–348
(2016)
368
H.-J. Im
nanorods in vivo by integrated analytical techniques: their uptake, retention, and chemical
forms. Anal. Bioanal. Chem. 396(3), 1105–1114 (2010)
61. J. Xiao, X.M. Tian, C. Yang, P. Liu, N.Q. Luo, Y. Liang et al., Ultrahigh relaxivity and safe
probes of manganese oxide nanoparticles for in vivo imaging. Sci. Rep. 3, 3424 (2013)
62. P. Bourrinet, H.H. Bengele, B. Bonnemain, A. Dencausse, J.-M. Idee, P.M. Jacobs et al.,
Preclinical safety and pharmacokinetic profile of ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent. Invest. Radiol. 41(3), 313–324 (2006)
63. C. Liu, Z. Gao, J. Zeng, Y. Hou, F. Fang, Y. Li et al., Magnetic/upconversion fluorescent
NaGdF4:Yb, Er nanoparticle-based dual-modal molecular probes for imaging tiny tumors
in vivo. ACS Nano 7(8), 7227–7240 (2013)
64. Y.N. Zhang, W. Poon, A.J. Tavares, I.D. McGilvray, W.C. Chan, Nanoparticle-liver
interactions: Cellular uptake and hepatobiliary elimination. J. Control Release 240, 332–348
(2016)
368
H.-J. Im
